Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).

Kazuya IchikadoToru KotaniYasuhiro KondohHideaki ImanakaTakeshi JohkohKiminori FujimotoShin NunomiyaTomotaka KawayamaMasanori SawadaEric JenkinsSadatomo TasakaSatoru Hashimoto

Published in: Stem cell research & therapy (2023)

ClinicalTrials.gov, Identifier: NCT03807804; January 8, 2019; https://clinicaltrials.gov/ct2/show/NCT03807804 .

Keyphrases

acute respiratory distress syndrome
extracorporeal membrane oxygenation
open label
mechanical ventilation
clinical trial
computed tomography
image quality
contrast enhanced
dual energy
study protocol
phase ii study
intensive care unit
young adults